| scholarly article | Q13442814 |
| P2093 | author name string | Y. Sato | |
| H. Sato | |||
| J. L. Cowell | |||
| C. R. Manclark | |||
| D. G. Burstyn | |||
| P2860 | cites work | Simple charring method for determination of lipids | Q72914480 |
| The purification of haptoglobin | Q78825339 | ||
| Pertussis Vaccine Prepared with Phase-I Cultures Grown in Fluid Medium | Q79880244 | ||
| Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes | Q93724247 | ||
| Protein measurement with the Folin phenol reagent | Q20900776 | ||
| Effect of lymphocytosis-promoting factor from Bordetella pertussis on cerebellar cyclic GMP levels | Q33912363 | ||
| Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen | Q34107352 | ||
| Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis | Q36359436 | ||
| Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis | Q36422760 | ||
| Biological activities of crystalline pertussigen from Bordetella pertussis | Q36427443 | ||
| Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. | Q36445467 | ||
| Crystallization of pertussigen from Bordetella pertussis | Q36455629 | ||
| Soluble adenylate cyclase from the culture medium of Bordetella pertussis: purification and characterization | Q36580106 | ||
| Biologically Active Components and Properties of Bordetella perfussis | Q39124508 | ||
| A sandwich method of enzymoimmunoassay. I. Application to rat and human alpha-fetoprotein | Q39351006 | ||
| Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization | Q40129361 | ||
| Biological Properties of Islets-Activating Protein (IAP) Purified from the Culture Medium of Bordetella pertussis | Q40129368 | ||
| Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography | Q40295514 | ||
| Selective breeding to establish a standard mouse for pertussis vaccine bioassay. II. Bioresponses of mice susceptible and resistant to sensitization by pertussis vaccine HSF | Q45235516 | ||
| A simple chemically defined medium for the production of phase I Bordetella pertussis | Q46714241 | ||
| Size and charge isomer separation and estimation of molecular weights of proteins by disc gel electrophoresis | Q47401199 | ||
| Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis | Q54607284 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiology | Q7193 |
| immunology | Q101929 | ||
| Bordetella pertussis | Q137103 | ||
| P304 | page(s) | 313-320 | |
| P577 | publication date | 1983-07-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Separation and purification of the hemagglutinins from Bordetella pertussis | |
| P478 | volume | 41 |
| Q35107455 | Adenylate cyclase toxin of Bordetella pertussis: production, purification, and partial characterization |
| Q36578698 | Adhesion of Bordetella pertussis to eukaryotic cells requires a time-dependent export and maturation of filamentous hemagglutinin |
| Q40802928 | Adverse reactions and antibody responses to acellular pertussis vaccine |
| Q37075121 | Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice |
| Q36989790 | Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis |
| Q34524012 | Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid. |
| Q34523360 | Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species |
| Q36363899 | Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). |
| Q36975158 | Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model |
| Q37041514 | Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system |
| Q33601872 | Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells |
| Q36956504 | Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule |
| Q36980977 | Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough |
| Q69882495 | Characterization of the filamentous hemagglutinin from Bordetella pertussis by gel electrophoresis |
| Q36968549 | Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis |
| Q36414874 | Cloning of the filamentous hemagglutinin of Bordetella pertussis and its expression in Escherichia coli |
| Q37055410 | Common themes in microbial pathogenicity |
| Q72406903 | Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice ofBordetella pertussis culture fluid, bacterial cells and cell extracts |
| Q36997301 | Dermonecrotic toxin and tracheal cytotoxin, putative virulence factors of Bordetella avium |
| Q34247807 | Development of a pertussis component vaccine in Japan |
| Q36988378 | Direct expression of Bordetella pertussis filamentous hemagglutinin in Escherichia coli and Salmonella typhimurium aroA |
| Q54172279 | Effect of hydromechanical forces on the production of filamentous haemagglutinin and pertussis toxin of Bordetella pertussis. |
| Q37017754 | Effect of monoclonal antibody to pertussis toxin on toxin activity |
| Q37171567 | Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis |
| Q35066267 | Fast, antigen-saving multiplex immunoassay to determine levels and avidity of mouse serum antibodies to pertussis, diphtheria, and tetanus antigens |
| Q30451122 | Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells |
| Q33849955 | Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence |
| Q34370945 | Human antibody response to the B oligomer of pertussis toxin |
| Q40267736 | Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis |
| Q35481628 | Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas |
| Q51044704 | Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory. |
| Q37079056 | In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor |
| Q30451157 | Interaction of monoclonal antibodies with pertussis toxin and its subunits |
| Q34661295 | Islet-activating protein (pertussis toxin) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release |
| Q69870759 | LPF-induced T cell colony formation: effect of PMA and interleukin-2, and surface marker analysis |
| Q37041543 | Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections |
| Q37156544 | Monoclonal antibody-based sandwich enzyme-linked immunosorbent assay for detection of Bordetella pertussis filamentous hemagglutinin |
| Q36986693 | Murine antibody response to oral infection with live aroA recombinant Salmonella dublin vaccine strains expressing filamentous hemagglutinin antigen from Bordetella pertussis. |
| Q40194283 | New, practical approach to detecting antibody to pertussis toxin for public health and clinical laboratories |
| Q69349419 | Outbreak of pertussis in a residential facility for handicapped people |
| Q90223870 | Pertussis Toxin: A Key Component in Pertussis Vaccines? |
| Q35106128 | Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen |
| Q35442880 | Pertussis toxin export genes are regulated by the ptx promoter and may be required for efficient translation of ptx mRNA in Bordetella pertussis |
| Q48474579 | Pertussis whole cell vaccine: relation between intracerebral protection in mice and antibody response to pertussis toxin, filamentous hemagglutinin and adenylate cyclase |
| Q36633486 | Pertussis: the disease and new diagnostic methods |
| Q37164324 | Preparation of filamentous hemagglutinin from Bordetella pertussis and assay for serum antibodies to filamentous hemagglutinin and pertussis toxin for clinical and public health laboratories |
| Q37080477 | Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis. |
| Q40149969 | Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatment |
| Q36990870 | Properties of the B oligomer of pertussis toxin |
| Q37035658 | Purification and characterization of fimbriae isolated from Bordetella pertussis. |
| Q37017758 | Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae |
| Q37056797 | Purification and subunit heterogeneity of pili of Bordetella bronchiseptica |
| Q44829332 | Rapid purification of pertussis toxin (PT) and filamentous hemagglutinin (FHA) by cation-exchange chromatography |
| Q37035495 | Resistance to adenovirus infection after administration of Bordetella pertussis vaccine in mice |
| Q37105742 | Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis |
| Q74031129 | Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children |
| Q67231990 | Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assay |
| Q40201311 | Simple, efficient purification of filamentous hemagglutinin and pertussis toxin from Bordetella pertussis by hydrophobic and affinity interaction. |
| Q72401220 | The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human T gamma and non-T gamma cells |
| Q36221230 | Two trans-acting regulatory genes (vir and mod) control antigenic modulation in Bordetella pertussis |
| Q40152070 | Uptake and intracellular survival of Bordetella pertussis in human macrophages |
| Q36158597 | Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features |
| Q64451161 | Virulence factors of Bordetella pertussis |
Search more.